Enjoy complimentary customisation on priority with our Enterprise License!
According to Technavio’s analyst, the global male infertility market is anticipated to grow at a steady rate and post a CAGR of close to 6% during the forecast period. The rising incidence of prostate cancer will drive the growth prospects for the global male infertility market until the end of 2021. In most cases, the treatment of this cancer requires the removal of the prostate gland, which results in impaired sexual function and infertility in men. Also, seminal vesicles that lie at the base of the bladder are completely removed during the process of prostatectomy and causes loss of semen, which makes the ejaculation impossible. In other cases, when the patient undergoes radiation therapy, the semen produced by radiated prostate cells and seminal vesicles loses its ability to transport well. Such conditions force several individuals to undergo fertility treatments, which drives the adoption rate of infertility treatment.
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market’s growth in the region includes the rise in infertility and obesity rates, and a lifestyle involving high consumption of liquor, substance abuse, and excessive smoking.
According to this industry research report, the global male infertility market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly undergoing mergers and acquisitions to extend their product portfolio and geographical presence. In addition, these vendors are increasingly focusing on research and developmental activities and are coming up with innovative products to gain a better competitive edge over their competitors. Intensive competition and excessive capital investment are some of the major challenges faced by the vendors.
Key vendors in this market are -
Other prominent vendors in the market include AbbVie, Apricus Biosciences, Aytu BioScience, Bristol-Myers Squibb, CooperSurgical, Medical Electronic Systems, OvaScience, MedITEX, and Xytex Cryo International.
The DNA fragmentation technique segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major factors responsible for the high rate of adoption of DNA fragmentation technique is its ability to offer an accurate result by measuring the amount of DNA damage. Also, since this technique often serves as an early fertility checkpoint, a large number of individuals go through this male fertility test, which eventually accelerates the rate of revenue generation in the market.
The fertility clinics segment accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. One of the major factors responsible for the market segment's growth is the increasing success rate of the male infertility treatment provided by infertility clinics, which accelerates the rate of inflow of infertility patients and gain popularity in both the domestic as well as the international market.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by under-lying cause
PART 07: Market segmentation by technique
PART 08: Market segmentation by end-user
PART 09: Geographical segmentation
PART 10: Decision framework
PART 11: Market drivers
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key Vendor Analysis
PART 15: Appendix
Tags: infertility treatment, ivf devices, lab supplies, health and wellness, male infertility market analysis, health and wellness market size,
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.